IMRA

Q: What is the price of Imara (IMRA) today?

The price of Imara (IMRA) today is $ 13.99, with return of 0% compared to the last year. The price of Imara (IMRA) started the year trading around $ 14.47 and today it is at $ 13.99. Follow the real-time price chart, the historical price of Imara (IMRA) and international markets.

Q: When does Imara (IMRA) pay dividends?

Imara (IMRA) distributed dividends in the last year,in the months of January and March totaling $ 0.51. The Dividend Yield for the last 12 months is 186.80%.

Q: Is Imara (IMRA) worth it?

Currently, Imara (IMRA) is priced at $ 13.99, with a P/E of 65.30%, representing a deviation of -366% from its historical average P/E. In the last year, the stock showed a variation of 0 in its price and distributed $ 0.51 in dividends, resulting in a Dividend Yield of 186.80%. The total shareholder return was 0.00%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Imara (IMRA) stock?

Investing in stocks of Imara (IMRA) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Imara (IMRA) yield today?

The yield of Imara (IMRA) was -7.64% in the last month, 0.00% in the last year and -24.44% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 27.82 in dividends, with a Dividend Yield of 186.80%.If you wanted to buy 100 stocks of Imara (IMRA) today, the total investment would be $ 1,399.00, based on the current price of $ 13.99.If past performance were to repeat, the return on your investment would be:In 1 year: $ 1,399.00In 5 years: $ 1,057.08In 10 years: $ 1,399.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Imara Inc.

Price

$ 13.99

return (12m)

0.00%

p/e

65.30

p/b

1.08

DIVIDEND YIELD

186.80%

price IMRA

IMRA

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of IMRA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-7.64%

3 months

-21.90%

1 year

0.00%

2 years

0.00%

5 years

-24.44%

10 years

0.00%

Fundamentals IMRA

review the fundamentals of Imara shares

P/E

65.30

Sector: -2.17 Industry: -5.92

P/S (Price-to-Sales)

Sector: 2.04 Industry: 3.20

P/B

1.08

Sector: 2.33 Industry: 2.50

DIVIDEND YIELD (DY)

186.80%

Sector: - Industry: -

ROA

1.62%

Sector: -27.04% Industry: -52.76%

ROE

1.65%

Sector: -30.90% Industry: -45.32%

ROIC

Sector: -420.29% Industry: -483.92%

NET MARGIN

0.00%

Sector: -28.97% Industry: -34.84%

GROSS MARGIN

0.00%

Sector: 44.33% Industry: 46.29%

OPERATING MARGIN

0.00%

Sector: -24.52% Industry: -30.48%

EV/EBITDA

48.44

Sector: -0.57 Industry: -4.17

EV/EBIT

69.65

Sector: -2.95 Industry: -5.95

PRICE-TO-ASSETS

1.06

Sector: 1.23 Industry: 1.45

BVPS

13.66

Sector: 3.48 Industry: 1.66

EPS

0.23

Sector: -0.89 Industry: -1.30

EQUITY-TO-ASSETS RATIO

0.98

Sector: 0.42 Industry: 0.46

LIABILITIES / ASSETS

0.02

Sector: 0.47 Industry: 0.43

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.00%

Sector: - Industry: -

FAIR VALUE OF Imara ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

$ 14.97

Fair Value

$ 0.00

Upside Return potential.

-43.84%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals IMRA

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/b	ROE	dy	market cap	net margin
LLY	45.62	39.48	86.53%	0.57%	$ 941.53 B	31.66%
ISRG	62.59	9.96	15.92%	0.00%	$ 178.75 B	28.38%
TMO	29.23	3.66	12.52%	0.33%	$ 195.94 B	15.05%
SNY	13.02	1.41	10.86%	4.55%	$ 118.78 B	18.68%
NVS	22.66	6.81	30.04%	2.34%	$ 316.95 B	24.67%
ABT	31.01	3.95	12.73%	2.06%	$ 202.33 B	14.72%
MDT	27.16	2.55	9.38%	2.90%	$ 125.30 B	13.00%
GSK	15.59	5.57	35.71%	2.82%	$ 118.88 B	17.48%
CVS	57.39	1.35	2.35%	3.33%	$ 101.47 B	0.44%
BSX	39.33	0.00	0.00%	0.00%	$ 113.97 B	14.44%
TMDX	53.82	13.90	25.84%	0.00%	$ 4.94 B	16.20%
HCA	17.80	-43.58	-244.82%	0.54%	$ 120.77 B	8.97%
IDXX	49.59	32.73	65.99%	0.00%	$ 52.54 B	24.62%
RMD	25.12	5.91	23.51%	0.88%	$ 37.33 B	27.53%
DHR	41.21	2.83	6.88%	0.61%	$ 148.92 B	14.71%
INMD	9.23	1.27	13.73%	0.00%	$ 866.25 M	25.32%
FMS	11.89	0.80	6.75%	3.35%	$ 13.42 B	5.02%
PHG	29.32	2.36	8.06%	2.77%	$ 30.42 B	5.07%
SYK	45.72	6.62	14.48%	0.88%	$ 148.40 B	12.92%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

IMRA Historical Dividends

current DY: 186.80%

5-year average DY: 186.80%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividend	02/27/2026	03/03/2026	0,30590000
Dividend	01/23/2026	01/27/2026	0,20800000
Dividend	12/26/2025	12/30/2025	1,41700000
Dividend	11/28/2025	12/02/2025	1,69400000
Dividend	10/24/2025	10/28/2025	3,01200000
Dividend	09/26/2025	09/30/2025	3,20000000
Dividend	08/22/2025	08/26/2025	2,90000000
Dividend	07/25/2025	07/29/2025	3,86500000
Dividend	06/27/2025	07/01/2025	1,89000000
Dividend	05/23/2025	05/28/2025	9,33000000

ABOUT THE COMPANY Imara

Imara Inc.

Average user rating I10

4.0 (3 people)

United States

10 years

Founded: 2016

2020

Time since IPO - 6 years

27

Employees

The Company Imara Inc. (United States), is listed on Nasdaq with a market value of $ 97.16 Millions, having an equity of $ 90.13 Millions.

With a total of 27 employees, the company is listed in the sector of Health and categorized in industry of Medical Supplies and Equipment.

In the last 12 months the Company had a revenue of $ -, which generated a profit in the amount of $ 1.49 Million.

As for its main indicators, the Company has a P/E ratio of 65.30, a P/BV ratio of 1.08 and in the last 12 months the dividend yield of IMRA was at 186.80%.

The Company is traded internationally through the ticker IMRA.

Market cap

$ 97.16 Millions

Net worth

$ 90.13 Millions

US$ 90,129,000.00

Assets

$ 91.96 Millions

US$ 91,959,000.00

Total Shares Outstanding

6.60 Millions

6,596,000

Average Daily Trading Volume

$ 6.95 Thousand

US$ 6,945.22

Sector

Health

Industry

Medical Supplies and Equipment

IMRA

IMRA revenue and profits

Financial Results IMRA

DRAG THE FRAME TO SEE MORE DATA

IMRA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/B

0.00

CVS - CVS Health

$ 80.49 30,14% (12M)

P/E

57.39

3.33%

ROE

2.35%

P/B

1.35

CI - Cigna

$ 283.93 --5,67% (12M)

P/E

11.22

2.08%

ROE

0.00%

P/B

0.00

CNC - Centene

$ 43.82 --24,28% (12M)

P/E

-3.31

0.00%

ROE

-33.28%

P/B

1.10

HUM - Humana

$ 181.58 --29,61% (12M)

P/E

17.71

1.86%

ROE

6.95%

P/B

1.23

HCA - HCA Healthcare

$ 541.80 75,21% (12M)

P/E

17.80

0.54%

ROE

-244.82%

P/B

-43.58

LLY - Eli Lilly

$ 1,007.73 9,37% (12M)

P/E

45.62

0.57%

ROE

86.53%

P/B

39.48

NVS - Novartis

$ 164.18 55,52% (12M)

P/E

22.66

2.34%

ROE

30.04%

P/B

6.81